MESCHIARI, MARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.370
EU - Europa 6.776
AS - Asia 6.670
SA - Sud America 1.070
AF - Africa 191
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
Totale 25.109
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.056
IT - Italia 2.683
SG - Singapore 2.150
CN - Cina 1.603
GB - Regno Unito 1.184
VN - Vietnam 839
HK - Hong Kong 764
BR - Brasile 745
DE - Germania 529
SE - Svezia 509
RU - Federazione Russa 362
FI - Finlandia 349
FR - Francia 307
KR - Corea 234
NL - Olanda 208
CA - Canada 190
ID - Indonesia 187
IN - India 176
AR - Argentina 112
TR - Turchia 96
BD - Bangladesh 94
BG - Bulgaria 83
MX - Messico 76
ES - Italia 74
UA - Ucraina 66
LT - Lituania 65
JP - Giappone 63
ZA - Sudafrica 63
IQ - Iraq 57
PL - Polonia 57
CO - Colombia 54
IR - Iran 53
CL - Cile 44
EC - Ecuador 44
PK - Pakistan 41
AE - Emirati Arabi Uniti 40
IE - Irlanda 40
AT - Austria 35
MY - Malesia 35
CZ - Repubblica Ceca 34
SI - Slovenia 33
MA - Marocco 30
BE - Belgio 27
TH - Thailandia 27
AU - Australia 24
CH - Svizzera 22
SA - Arabia Saudita 22
JO - Giordania 21
PH - Filippine 21
VE - Venezuela 21
UZ - Uzbekistan 19
RO - Romania 16
EG - Egitto 15
KZ - Kazakistan 15
NP - Nepal 15
PY - Paraguay 15
IL - Israele 14
PE - Perù 14
TN - Tunisia 14
GR - Grecia 13
DO - Repubblica Dominicana 12
BO - Bolivia 11
KE - Kenya 11
DZ - Algeria 10
TW - Taiwan 10
AZ - Azerbaigian 9
PS - Palestinian Territory 9
AL - Albania 8
CR - Costa Rica 8
HU - Ungheria 8
LV - Lettonia 8
SN - Senegal 8
UY - Uruguay 8
BH - Bahrain 7
GE - Georgia 7
JM - Giamaica 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
DK - Danimarca 6
NG - Nigeria 6
PA - Panama 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
BY - Bielorussia 5
ET - Etiopia 5
MD - Moldavia 5
CI - Costa d'Avorio 4
CY - Cipro 4
EE - Estonia 4
MK - Macedonia 4
NO - Norvegia 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BF - Burkina Faso 3
BZ - Belize 3
CG - Congo 3
EU - Europa 3
GA - Gabon 3
HR - Croazia 3
Totale 25.047
Salva come PNG Salva come JPEG
Città #
Ashburn 1.414
Singapore 1.373
Santa Clara 1.286
Fairfield 779
Hong Kong 741
Southend 653
Chandler 638
San Jose 612
Hefei 535
Nyköping 333
Woodbridge 303
Houston 292
Cambridge 291
London 282
Ho Chi Minh City 273
Seattle 271
Helsinki 268
Beijing 256
Los Angeles 238
New York 234
Seoul 225
Council Bluffs 215
Wilmington 212
Modena 191
Hanoi 184
Bologna 179
Dallas 172
Milan 172
Rome 171
Munich 165
Chicago 150
Jakarta 150
San Diego 138
The Dalles 116
Ann Arbor 114
Lauterbourg 100
Shanghai 95
Moscow 91
Princeton 76
São Paulo 71
Sofia 70
Frankfurt am Main 67
Toronto 67
Buffalo 62
Parma 59
Bremen 55
Amsterdam 51
Orem 51
Naples 50
Tokyo 50
Warsaw 47
Turku 46
Da Nang 45
Jacksonville 45
Dearborn 43
Atlanta 39
Hillsboro 39
Boardman 38
Montreal 38
Paris 38
North York 37
Redwood City 36
Reggio Emilia 36
Palermo 34
Salt Lake City 34
Fremont 33
Johannesburg 31
Phoenix 31
Stockholm 31
Nuremberg 30
Dublin 29
Kent 28
Redondo Beach 28
Turin 28
Chennai 27
Rio de Janeiro 27
Haiphong 26
Mexico City 26
Brooklyn 25
Catania 25
Denver 25
Florence 25
Mumbai 25
Poplar 25
Madrid 24
Lappeenranta 23
Santiago 23
Brussels 22
Portsmouth 22
Belo Horizonte 21
Columbus 21
Des Moines 21
Grafing 21
Izmir 21
Rimini 21
Verona 21
Bari 20
Biên Hòa 20
Dong Ket 20
Guangzhou 20
Totale 16.102
Salva come PNG Salva come JPEG
Nome #
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 789
Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach 646
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 525
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 505
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 454
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 448
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. 435
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 429
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 395
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 379
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 367
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 365
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 362
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 356
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 342
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 332
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 332
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 330
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 330
Ectopic fat is linked to prior cardiovascular events in men with HIV. 327
Hypokalemia in Patients with COVID-19 310
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature 303
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination 297
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 287
Peritoneal dialysis in the time of coronavirus disease 2019 286
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 283
Metabolic reprograming shapes neutrophil functions in severe COVID-19 275
Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol 269
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period 266
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 265
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 261
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature 255
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions 248
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 246
Infective complications in patients undergoing surgical reconstruction with dermal matrix: the Modena experience 245
Changing in the post-surgery infective complications following the shortening of the antibiotic prophylaxis in the patients undergoing skin dermal substitutes reconstruction 244
Epidemiology and Risk Factors Associated with Mortality in Consecutive Patients with Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria 244
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 241
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 240
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 238
Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART 236
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections 234
A retrospective whole-genome sequencing analysis of carbapenem and colistin-resistant klebsiella pneumoniae nosocomial strains isolated during an MDR surveillance program 233
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients 230
Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection 230
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. 230
Treating cancer with immunotherapy in HIV-positive patients: A challenging reality 229
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. 228
Comparison of two perioperative antibiotic schedules in patients undergoing surgical reconstruction with dermal matrix after excision of skin cancer 225
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 221
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 220
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 214
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 210
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 210
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 208
Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab 206
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? 203
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 202
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 198
Critical COVID-19 Patients Through First, Second And Third Wave: Retrospective Observational Study Comparing Outcomes In ICU. 196
Combined resistance to ceftolozane-tazobactam and ceftazidime-avibactam in extensively drug-resistant (Xdr) and multidrug-resistant (mdr) pseudomonas aeruginosa: Resistance predictors and impact on clinical outcomes besides implications for antimicrobial stewardship programs 194
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 193
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 193
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 191
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 190
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 187
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: a practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases 186
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 186
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study 186
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales 181
Role of selective digestive decontamination in the prevention of VAP in COVID-19 patients: a pre-post observational study. 179
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 178
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 169
The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae 168
Perioperative Use of IgM-Enriched Immunoglobulins in Liver Transplantation Recipients at High Risk for Infections: A Preliminary Study 166
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 166
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 161
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia 158
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 158
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT) 156
A rare case of necrotizing fasciitis of the leg in an intravenous drug user caused by Prevotella denticola 151
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study) 151
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients 151
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review 148
A time-series analysis approach to quantify change in antibiotic resistance and antibiotic consumption during COVID-19 Epidemics: a multicenter cross-national ecological study on behalf of QUARANTINE (QUantifying change in Antibiotic Resistance, ANTibiotic use, and INfection control during COVID-19 Epidemics) study project 147
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 146
Continued decay of HIV proviral DNA upon vaccination with HIV-1 Tat of subjects on long-term ART: An 8-year follow-up study 145
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 141
Efficacy of bezlotoxumab in preventing recurrence of Clostridioides difficile infection: an Italian multicenter cohort study 139
First Human Case of Tick-Borne Encephalitis in Non-Endemic Region in Italy: A Case Report 132
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study 130
The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models 129
Tocilizumab for severe COVID-19 pneumonia – Authors' reply 128
Impact of VRE-active perioperative prophylaxis in liver transplant patients colonized by Vancomycin-Resistant Enterococci 124
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab 121
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience 120
Streptococcus equi Subspecies zooepidemicus Endocarditis and Meningitis in a 62-Year-Old Horse Rider Patient: A Case Report and Literature Review 118
Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia 112
New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA) 110
Reduction trend of mcr-1 circulation in Emilia-Romagna Region, Italy 109
Totale 24.312
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.051
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021442 0 0 0 0 0 0 0 0 0 0 249 193
2021/20222.228 149 141 167 69 114 148 266 122 232 160 406 254
2022/20232.405 272 293 195 215 238 272 74 203 278 71 140 154
2023/20242.281 89 135 163 194 374 222 174 256 104 105 181 284
2024/20255.528 198 120 133 389 909 874 444 328 610 312 551 660
2025/20269.751 822 503 897 1.225 1.407 589 1.338 592 1.117 1.149 112 0
Totale 25.368